Report Detail
Global Insomnia Treatment Drugs Market Size, Status and Forecast 2019-2025
- RnM3669128 |
- 14 August, 2019 |
- Global |
- 91 Pages |
- QYResearch |
- Pharma & Healthcare
Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.
In 2018, the global Insomnia Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Insomnia Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Insomnia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Market segment by Type, the product can be split into
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Market segment by Application, split into
Hospital
Pharmacy
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Insomnia Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Insomnia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Insomnia Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Insomnia Treatment Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Prescription Sleep Aids
- 1.4.3 Over the Counter (OTC) Sleep Aids
- 1.5 Market by Application
- 1.5.1 Global Insomnia Treatment Drugs Market Share by Application (2019-2025)
- 1.5.2 Hospital
- 1.5.3 Pharmacy
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Insomnia Treatment Drugs Market Size
- 2.2 Insomnia Treatment Drugs Growth Trends by Regions
- 2.2.1 Insomnia Treatment Drugs Market Size by Regions (2019-2025)
- 2.2.2 Insomnia Treatment Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Insomnia Treatment Drugs Market Size by by Players
- 3.1.1 Global Insomnia Treatment Drugs Revenue by by Players (2014-2019)
- 3.1.2 Global Insomnia Treatment Drugs Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Insomnia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Insomnia Treatment Drugs Key Players Head office and Area Served
- 3.3 Key Players Insomnia Treatment Drugs Product/Solution/Service
- 3.4 Date of Enter into Insomnia Treatment Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Insomnia Treatment Drugs Market Size by Type (2014-2019)
- 4.2 Global Insomnia Treatment Drugs Market Size by Application (2014-2019)
5 North America
- 5.1 North America Insomnia Treatment Drugs Market Size (2014-2019)
- 5.2 Insomnia Treatment Drugs Key Players in North America
- 5.3 North America Insomnia Treatment Drugs Market Size by Type
- 5.4 North America Insomnia Treatment Drugs Market Size by Application
6 Europe
- 6.1 Europe Insomnia Treatment Drugs Market Size (2014-2019)
- 6.2 Insomnia Treatment Drugs Key Players in Europe
- 6.3 Europe Insomnia Treatment Drugs Market Size by Type
- 6.4 Europe Insomnia Treatment Drugs Market Size by Application
7 China
- 7.1 China Insomnia Treatment Drugs Market Size (2014-2019)
- 7.2 Insomnia Treatment Drugs Key Players in China
- 7.3 China Insomnia Treatment Drugs Market Size by Type
- 7.4 China Insomnia Treatment Drugs Market Size by Application
8 Japan
- 8.1 Japan Insomnia Treatment Drugs Market Size (2014-2019)
- 8.2 Insomnia Treatment Drugs Key Players in Japan
- 8.3 Japan Insomnia Treatment Drugs Market Size by Type
- 8.4 Japan Insomnia Treatment Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Insomnia Treatment Drugs Market Size (2014-2019)
- 9.2 Insomnia Treatment Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Insomnia Treatment Drugs Market Size by Type
- 9.4 Southeast Asia Insomnia Treatment Drugs Market Size by Application
10 India
- 10.1 India Insomnia Treatment Drugs Market Size (2014-2019)
- 10.2 Insomnia Treatment Drugs Key Players in India
- 10.3 India Insomnia Treatment Drugs Market Size by Type
- 10.4 India Insomnia Treatment Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Insomnia Treatment Drugs Market Size (2014-2019)
- 11.2 Insomnia Treatment Drugs Key Players in Central & South America
- 11.3 Central & South America Insomnia Treatment Drugs Market Size by Type
- 11.4 Central & South America Insomnia Treatment Drugs Market Size by Application
12 International Players Profiles
- 12.1 F.Hoffman La-Roche AG
- 12.1.1 F.Hoffman La-Roche AG Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Insomnia Treatment Drugs Introduction
- 12.1.4 F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2014-2019))
- 12.1.5 F.Hoffman La-Roche AG Recent Development
- 12.2 Merck & Co. Inc.
- 12.2.1 Merck & Co. Inc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Insomnia Treatment Drugs Introduction
- 12.2.4 Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2014-2019)
- 12.2.5 Merck & Co. Inc. Recent Development
- 12.3 Mylan N.V.
- 12.3.1 Mylan N.V. Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Insomnia Treatment Drugs Introduction
- 12.3.4 Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2014-2019)
- 12.3.5 Mylan N.V. Recent Development
- 12.4 Pfizer, Inc.
- 12.4.1 Pfizer, Inc. Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Insomnia Treatment Drugs Introduction
- 12.4.4 Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2014-2019)
- 12.4.5 Pfizer, Inc. Recent Development
- 12.5 Pernix Therapeutics
- 12.5.1 Pernix Therapeutics Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Insomnia Treatment Drugs Introduction
- 12.5.4 Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2014-2019)
- 12.5.5 Pernix Therapeutics Recent Development
- 12.6 Sanofi S.A.
- 12.6.1 Sanofi S.A. Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Insomnia Treatment Drugs Introduction
- 12.6.4 Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2014-2019)
- 12.6.5 Sanofi S.A. Recent Development
- 12.7 Takeda Pharmaceutical Company Ltd.
- 12.7.1 Takeda Pharmaceutical Company Ltd. Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Insomnia Treatment Drugs Introduction
- 12.7.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2014-2019)
- 12.7.5 Takeda Pharmaceutical Company Ltd. Recent Development
- 12.8 Sumitomo Dainippon Pharma Co., Ltd
- 12.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Insomnia Treatment Drugs Introduction
- 12.8.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2014-2019)
- 12.8.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
- 12.9 Teva Pharmaceutical Industries Ltd.
- 12.9.1 Teva Pharmaceutical Industries Ltd. Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Insomnia Treatment Drugs Introduction
- 12.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2014-2019)
- 12.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
- 12.10 Vanda Pharmaceuticals, Inc.
- 12.10.1 Vanda Pharmaceuticals, Inc. Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Insomnia Treatment Drugs Introduction
- 12.10.4 Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2014-2019)
- 12.10.5 Vanda Pharmaceuticals, Inc. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Insomnia Treatment Drugs. Industry analysis & Market Report on Insomnia Treatment Drugs is a syndicated market report, published as Global Insomnia Treatment Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Insomnia Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
